XLAB Exascale Labs Holdings Inc.

Fundamentals / CIK 0002109869 / USD
Other share classes on CIK 0002109869: XLABW

Exascale Labs Holdings Inc. reported $14.82M in revenue and a net loss of $12.16M for the fiscal year ended June 30, 2026 (up 111.3% year over year), with a 16.3% gross margin and a -32.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XLAB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2025 to 2026), reported in USD.

$15.89M$7.95M$0-$12.63MFY 2025 Revenue: $7.02MFY 2025 Net Income: -$7.66M2025FY 2026 Revenue: $14.82MFY 2026 Net Income: -$12.16M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Jun 30 Jun 30
Revenue $14.82M $7.02M
Cost of Revenue $12.40M $5.91M
Gross Profit $2.42M $1.11M
Research & Development $5.49M $2.80M
Selling, General & Admin $1.73M $1.35M
Total Operating Expenses $7.22M $4.15M
Operating Income -$4.80M -$3.04M
EBITDA -$4.79M -$3.04M
Income Before Tax -$12.16M -$7.66M
Net Income -$12.16M -$7.66M
Basic EPS -$8,108.26 -$5,106.44
Diluted EPS -$8,108.26 -$5,106.44
Basic Shares Outstanding 1.5K 1.5K
Diluted Shares Outstanding 1.5K 1.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2025-09-30
Revenue $4.33M $3.26M
Cost of Revenue $3.75M $2.71M
Gross Profit $582K $551K
Research & Development $1.28M $865K
Selling, General & Admin $840K $295K
Total Operating Expenses $2.12M $1.16M
Operating Income -$1.54M -$609K
EBITDA -$1.54M -$607K
Income Before Tax -$11.38M -$1.52M
Net Income -$11.38M -$1.52M
Basic EPS -$0.21 -$0.03
Diluted EPS -$0.21 -$0.03
Basic Shares Outstanding 55.3M 50.0M
Diluted Shares Outstanding 55.3M 50.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Jun 30 Jun 30
Cash & Cash Equivalents $2.69M $4.23M
Cash & Short-Term Investments $2.69M $4.23M
Accounts Receivable, Net $1.15M $153K
Total Current Assets $6.52M $7.30M
Property, Plant & Equipment, Net $13K $20K
Total Non-Current Assets $203K $20K
Total Assets $6.73M $7.32M
Accounts Payable $916K $90K
Total Current Liabilities $31.89M $20.32M
Total Non-Current Liabilities $0 $0
Total Liabilities $31.89M $20.32M
Common Stock -- $15
Retained Earnings -$25.38M -$13.22M
Total Stockholders' Equity -$25.16M -$13.00M
Total Equity -$25.16M -$13.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2025-06-30
Cash & Cash Equivalents $12.83M $2.69M $4.23M
Cash & Short-Term Investments $12.83M $2.69M $4.23M
Accounts Receivable, Net $1.58M $1.15M $153K
Total Current Assets $17.21M $6.52M $7.30M
Property, Plant & Equipment, Net $11K $13K $20K
Total Non-Current Assets $11K $203K $20K
Total Assets $17.22M $6.73M $7.32M
Accounts Payable $2.02M $916K $90K
Total Current Liabilities $3.55M $31.89M $20.32M
Total Non-Current Liabilities $0 $0 $0
Total Liabilities $3.55M $31.89M $20.32M
Common Stock -- -- $15
Retained Earnings -$36.76M -$25.38M -$13.22M
Total Stockholders' Equity $13.67M -$25.16M -$13.00M
Total Equity $13.67M -$25.16M -$13.00M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Jun 30 Jun 30
Net Income -$12.16M -$7.66M
Depreciation & Amortization $6.8K $6.2K
Stock-Based Compensation $0 $153K
Change in Receivables -$993K -$29K
Change in Payables $826K -$38K
Operating Cash Flow -$2.75M -$1.01M
Capital Expenditure -- -$2.1K
Free Cash Flow -- -$1.01M
Investing Cash Flow $1.41M -$2.1K
Financing Cash Flow -$190K $4.28M
Net Change in Cash -$1.54M $3.26M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2025-09-30
Net Income -$11.38M -$1.52M
Depreciation & Amortization $1.6K $2.1K
Stock-Based Compensation $0 $0
Change in Receivables -$432K -$687K
Change in Payables $1.11M $68K
Operating Cash Flow -$648K -$3.77M
Investing Cash Flow -$550K --
Financing Cash Flow $11.34M -$50K
Net Change in Cash $10.14M -$3.82M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Jun 30 Jun 30
Gross Margin 16.3% 15.8%
Operating Margin -32.4% -43.4%
Net Profit Margin -82.1% -109.2%
Return on Assets (ROA) -180.8% -104.6%
Current Ratio 0.20x 0.36x
Quick Ratio 0.12x 0.22x
Revenue Growth (YoY) +111.3% --
Gross Profit Growth (YoY) +118.8% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2025-09-30
Current Ratio 4.85x --
Quick Ratio 4.06x --
Revenue Growth (YoY) +32.8% --
Gross Profit Growth (YoY) +5.6% --
Source: SEC EDGAR CompanyFacts (CIK 0002109869) · from June 30, 2025 Data through September 30, 2026 · synced Nov 21, 2026, 05:03 UTC · Open in terminal